A longitudinal single-cell atlas of treatment response in pediatric AML
Cancer Cell · 2023-12 · 41 (12) · 2117-2135.e12
DOI: 10.1016/j.ccell.2023.10.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2023-12. Verfasst von Sander Lambo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of British Columbia, Canadian Institutes of Health Research, BC Cancer Foundation.
Abstract (Originalsprache)
Pediatric acute myeloid leukemia (pAML) is characterized by heterogeneous cellular composition, driver alterations and prognosis. Characterization of this heterogeneity and how it affects treatment response remains understudied in pediatric patients. We used single-cell RNA sequencing and single-cell ATAC sequencing to profile 28 patients representing different pAML subtypes at diagnosis, remission and relapse. At diagnosis, cellular composition differed between genetic subgroups. Upon relapse, cellular hierarchies transitioned toward a more primitive state regardless of subtype. Primitive cells in the relapsed tumor were distinct compared to cells at diagnosis, with under-representation of myeloid transcriptional programs and over-representation of other lineage programs. In some patients, this was accompanied by the appearance of a B-lymphoid-like hierarchy. Our data thus reveal the emergence of apparent subtype-specific plasticity upon treatment and inform on potentially targetable processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
- Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
- British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada; Department of Pathology & Laboratory Medicine, Division of Hematopathology, Children's and Women's Health Centre of British Columbia, Vanco…
- Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada; Department of Medical Genetics and Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada.
- Hematologics, Incorporated, Seattle, WA, USA.
- Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Förderung
- University of British Columbia
- Canadian Institutes of Health Research
- BC Cancer Foundation
- Canada Foundation for Innovation
- Genome British Columbia
- Michael Smith Health Research BC
- Canada Research Chairs
- Genome Canada
Zitieren
APA
Lambo, S., Trinh, D. L., Ries, R. E., Jin, D., Setiadi, A., Ng, M., Leblanc, V. G., Loken, M. R., Brodersen, L. E., Dai, F., Pardo, L. M., Ma, X., Vercauteren, S. M., Meshinchi, S., & Marra, M. A. (2023). A longitudinal single-cell atlas of treatment response in pediatric AML. Cancer Cell, 41(12), 2117-2135.e12. https://doi.org/10.1016/j.ccell.2023.10.008
Vancouver
Lambo S, Trinh DL, Ries RE, Jin D, Setiadi A, Ng M, et al. A longitudinal single-cell atlas of treatment response in pediatric AML. Cancer Cell. 2023;41(12):2117-2135.e12. doi:10.1016/j.ccell.2023.10.008
BibTeX
@article{Lambo2023,
author = {Lambo, Sander and Trinh, Diane L and Ries, Rhonda E and Jin, Dan and Setiadi, Audi and Ng, Michelle and Leblanc, Veronique G and Loken, Michael R and Brodersen, Lisa E and Dai, Fangyan and Pardo, Laura M and Ma, Xiaotu and Vercauteren, Suzanne M and Meshinchi, Soheil and Marra, Marco A},
title = {A longitudinal single-cell atlas of treatment response in pediatric AML},
journal = {Cancer Cell},
year = {2023},
volume = {41},
number = {12},
pages = {2117--2135.e12},
doi = {10.1016/j.ccell.2023.10.008}
}
EUVIMED